Applied Physiology of Exercise Lab · University of Virginia

Turning exercise into vascular medicine.

We study how exercise — paired with nutritional and pharmacological strategies — restores vascular function and functional capacity in people with limited therapeutic options: peripheral artery disease, heart failure, aging adults, and women after menopause. One of our major focus areas is the restoration of nitric oxide bioavailability.

NO3
Dietary nitrate
NO2
Nitrite
NO
Nitric oxide
The pathway at the center of two decades of our work — from the plate to the vessel wall
100+
Peer-reviewed papers
$3.5M
Active NIH R01 (PRIME-HFrEF)
20+
Trainees mentored
2
UVA schools bridged

What we do

Vascular biology and clinical exercise physiology, working the same problem from both ends.

The APEX Lab sits between the Department of Kinesiology and the Division of Cardiovascular Medicine at the University of Virginia. That dual footing is the point: we pair mechanistic vascular science with the practical craft of prescribing exercise for people who are sick, deconditioned, or aging.

Our through-line is the nitrate–nitrite–nitric oxide pathway — the body's own route to widening blood vessels and delivering oxygen to working muscle. When exercise alone isn't enough, raising nitric oxide availability can help the vessels keep up.

We run randomized clinical trials, measure vascular function and muscle perfusion directly, and translate what we learn into exercise prescriptions that patients can actually complete. The lab is co-directed within the Robert M. Berne Cardiovascular Research Center.

Increasingly, our attention is on populations that cardiovascular research has historically underserved — most of all women navigating the sharp rise in cardiovascular risk that follows menopause.

Four programs

The programs the lab is built around.

Signature finding

The first evidence that a drink could do what drugs couldn't.

In 2011, our randomized trial showed that a single dose of dietary inorganic nitrate raised plasma nitrite and extended claudication-free walking time in patients with peripheral artery disease — the first clinical evidence that a non-pharmacological nitric-oxide precursor could move a meaningful functional endpoint in any clinical population.

The paper has been cited more than 440 times and continues to accumulate roughly 30 citations a year, seeding funded programs in our lab and many others.

Kenjale et al. 2011

"Dietary Nitrate Supplementation Enhances Exercise Performance in Peripheral Arterial Disease."

Journal of Applied Physiology · 440+ citations · PMID 21454745

See the publications